← Back to Search

Behavioural Intervention

sleep extension intervention arm for Sleep Deprivation

Q: Are individuals still being enrolled for participation in this clinical trial?

Indeed, the data available on clinicaltrials.gov confirms that this study is presently in the recruitment phase. The trial was originally posted on October 1st, 2023 and underwent its most recent update on January 16th, 2024. It aims to enroll a total of 90 participants at a single location.

Q: What is the upper limit on the number of individuals participating in this clinical investigation?

Indeed, the information provided on clinicaltrials.gov highlights that this particular clinical trial is actively seeking eligible participants. The trial was initially posted on October 1st, 2023 and underwent its most recent update on January 16th, 2024. In total, the study aims to enroll a cohort of 90 patients from a single site.

Q: Is the age limit for participating in this study set at 25 years or older?

To be eligible for this clinical trial, prospective participants must fall within the age range of 21 to 75 years. It is noteworthy that there are a total of 178 studies focused on patients under the age of 18 and an additional 617 studies targeting individuals over the age of 65.

Phase 1 & 2

Recruiting

Led By Ivan Wu, PhD

Research Sponsored by University of Minnesota

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 10 weeks

Awards & highlights

Study Summary

This trial aims to reduce health disparities related to obesity in African Americans by promoting healthy lifestyle behaviors. The trial will consist of two phases. Phase 1 involves conducting interviews to better understand sleep-related factors and

Who is the study for?

This trial is for African American adults who are not very active, sleep less than 6 hours a night, and are overweight or obese. It's designed to see if improving sleep can help with weight and health issues. People with certain medical conditions that could affect the study may not be able to join.Check my eligibility

What is being tested?

The study tests whether a program aimed at helping participants sleep more (sleep extension intervention) can improve their health compared to regular check-ins without specific sleep advice (contact control intervention). The first phase gathers information, while the second phase tests the actual interventions.See study design

What are the potential side effects?

Since this trial involves non-medical interventions like changing sleeping habits, side effects might include changes in mood or alertness due to altered sleep patterns. However, significant physical side effects are unlikely.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 10 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~10 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility of the sleep intervention

Satisfaction with the sleep intervention

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: sleep extension intervention armExperimental Treatment1 Intervention

sedentary and short sleep (=<6 hrs/night) African American adults with overweight/obesity randomized to the sleep extension intervention.

Group II: education contact control armActive Control1 Intervention

sedentary and short sleep (=<6 hrs/night) African American adults with overweight/obesity randomized to contact control intervention.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor

1,381 Previous Clinical Trials

1,588,885 Total Patients Enrolled

1 Trials studying Sleep Deprivation

90 Patients Enrolled for Sleep Deprivation

Ivan Wu, PhDPrincipal InvestigatorUniversity of Minnesota

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals still being enrolled for participation in this clinical trial?

"Indeed, the data available on clinicaltrials.gov confirms that this study is presently in the recruitment phase. The trial was originally posted on October 1st, 2023 and underwent its most recent update on January 16th, 2024. It aims to enroll a total of 90 participants at a single location."

Answered by AI

What is the upper limit on the number of individuals participating in this clinical investigation?

"Indeed, the information provided on clinicaltrials.gov highlights that this particular clinical trial is actively seeking eligible participants. The trial was initially posted on October 1st, 2023 and underwent its most recent update on January 16th, 2024. In total, the study aims to enroll a cohort of 90 patients from a single site."

Answered by AI

Is the age limit for participating in this study set at 25 years or older?

"To be eligible for this clinical trial, prospective participants must fall within the age range of 21 to 75 years. It is noteworthy that there are a total of 178 studies focused on patients under the age of 18 and an additional 617 studies targeting individuals over the age of 65."

Answered by AI